Myocarditis Isn’t Contagious, But Viruses Can Be

Myocarditis itself is not contagious. It is inflammation of the heart muscle, and inflammation cannot spread from one person to another. However, the viruses that most commonly trigger myocarditis are contagious, and those viruses can spread through respiratory droplets, contaminated surfaces, or the fecal-oral route. The important distinction is that catching one of these viruses does not mean you will develop myocarditis. Most people fight off the infection without any heart involvement.

Why the Viruses Spread but the Heart Damage Doesn’t

Myocarditis develops when something damages heart muscle cells, called cardiomyocytes. In most cases, that “something” is a virus that has traveled from its initial site of infection (usually the respiratory or gastrointestinal tract) to the heart. Once the virus reaches heart tissue, it can injure cells directly. Your immune system then sends waves of defense cells into the heart to contain the virus, and in some people this immune response itself causes additional damage to the heart muscle.

This process unfolds in phases. In the acute phase, the virus directly harms heart cells with only minimal immune activity. In the subacute phase, specialized immune cells flood the heart, identify virus-infected cells, and destroy them. In some cases, a chronic phase follows in which the immune system continues attacking heart tissue even after the virus is cleared, resembling an autoimmune reaction. The inflammation that results from all of this is a consequence of infection, not something that can jump between people.

Which Viruses Cause Myocarditis

Nearly a quarter of viral myocarditis cases are attributed to enteroviruses, with coxsackieviruses being the most common in that group. These viruses primarily live in the gastrointestinal tract and spread through the fecal-oral route, meaning contaminated hands, water, or surfaces. Despite starting in the gut, enteroviruses can cause damage well beyond it, including in the heart.

Respiratory viruses make up another major category. These enter through the airways, multiply in the lining of the respiratory tract, and occasionally cause tissue damage elsewhere in the body. This group includes influenza, adenoviruses, respiratory syncytial virus (RSV), measles, and SARS-CoV-2. Parvovirus B19, another known trigger, can spread through the airways, the gastrointestinal tract, blood products, and from mother to child during pregnancy.

The key point: you can catch these viruses from someone else, but you cannot catch myocarditis from someone who has it. Whether a virus goes on to inflame your heart depends on your own immune response and other individual factors, not on how you were exposed.

Causes That Have Nothing to Do With Infection

Not all myocarditis is triggered by a virus. A significant number of cases stem from causes that are entirely non-contagious. Autoimmune conditions like lupus, rheumatoid arthritis, and sarcoidosis can cause the immune system to attack heart tissue on its own. Giant cell myocarditis, a rare but serious form, involves the immune system targeting the heart without any preceding infection.

Toxic exposures are another category. Cocaine, amphetamines, alcohol, and certain chemotherapy drugs can all inflame the heart muscle. Heavy metals like lead, copper, and iron can do the same. Some people develop myocarditis as a hypersensitivity reaction to medications, including certain antibiotics and antiseizure drugs. None of these causes involve a transmissible agent.

Who Is Most at Risk

Males develop myocarditis more often than females. CDC data from a large hospital-based study found that among patients with COVID-19, the risk of myocarditis was 0.187% in males compared to 0.109% in females. By age, the risk was highest in adults 75 and older (0.238%) and children under 16 (0.133%), with the lowest rates in young adults aged 25 to 39 (0.077%).

These numbers reflect one specific viral trigger (SARS-CoV-2), but the general pattern holds across other causes: males and people at the extremes of age tend to be more vulnerable. Young, otherwise healthy adults can still develop myocarditis, particularly after viral infections, so age alone does not determine risk.

COVID-19 and Myocarditis Risk

Because of widespread concern during the pandemic, the relationship between SARS-CoV-2 infection, vaccination, and myocarditis has been studied extensively. A meta-analysis covering 55.5 million vaccinated individuals and 2.5 million people who were infected found that the risk of myocarditis was more than seven times higher after a SARS-CoV-2 infection than after vaccination. Infection increased the risk roughly 15-fold compared to baseline, while vaccination increased it roughly 2-fold. These findings were consistent with a separate analysis of electronic health records from 40 U.S. healthcare systems.

Symptoms to Recognize

Myocarditis can be asymptomatic, but when it does produce symptoms, chest pain is the most common, appearing in 85 to 95% of cases. Fever occurs in about 65% of patients, and shortness of breath in 19 to 49%. Palpitations, fainting, and fatigue are also reported. These symptoms often appear days to weeks after a viral illness, which is one of the reasons myocarditis can initially be mistaken for a heart attack. Both conditions can produce similar changes on an ECG, including a pattern called ST segment elevation.

About 26% of patients with acute myocarditis present with complications: reduced heart pumping function, dangerous heart rhythm disturbances, or a fulminant course that includes dangerously low blood output. Markers of heart injury in the blood, such as troponin, are often elevated but can also be normal, so a negative blood test does not rule it out. Cardiac MRI with contrast is one of the most reliable tools for confirming the diagnosis.

Recovery and Long-Term Outlook

About half of patients with biopsy-confirmed myocarditis recover within two to four weeks. During recovery, exercise restriction is standard for three to six months to avoid stressing the healing heart muscle. For many people, particularly those with mild cases, the heart returns to normal function without lasting damage.

Complications can be severe, though. They include heart failure involving one or both sides of the heart, persistent rhythm disturbances, and in rare cases, cardiogenic shock or death. How often mild cases progress to these more serious outcomes is not well established. The uncertainty around progression is one reason that even people who feel fine after a myocarditis diagnosis are typically monitored with follow-up imaging and heart function tests over the months that follow.